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e-mail address: rebner@intramed.net (R.N. Ebner).Roberto N. Ebner ⇑, Dolores Ribero Ayerza, Fernando AghetoniAbstractPurpose: To present five patients with VIth nerve palsy and ipsilateral Horner’s Syndrome (HS), as a result of cavernous sinus
alteration.
Study design: Consecutive case series.
Material and methods: Five patients presented abducens palsy with horizontal diplopia (3 in primary position and 2 in lateral gaze
only) and ipsilateral HS.
Apraclonidine 0.5% drops evidenced sympathetic denervation in all patients 40–60 min after instillation. All 5 cases had
neuroimages (MRI in 3 cases, Computerized Tomography – CT in one case and Magnetic Resonance Angiography – MRA in
one case) demonstrating cavernous sinus lesions; 2 meningiomas, 1 carotid-cavernous aneurism, 1 foreign body (bullet) and
1 squamous cell carcinoma.
Conclusion: Lesions on the cavernous sinus need to be considered in cases of abducens nerve palsy and ipsilateral Horner’s
Syndrome.
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Disfunction of the sixth (abducens) cranial nerve may result
from lesions occurring anywhere along its pathway between
the sixth nerve nucleus in the dorsal pons and the lateral rec-
tus muscle within the orbit.
Horner Syndrome can be caused by damage to the
sympathetic pathway at any location of its route from the
hypothalamus to the eye.
The association of the sixth nerve palsy with ipsilateral
Horner’s Syndrome has a localizing value in the posterior cav-
ernous sinus, also known as Parkinson’s Syndrome.
The syndrome has been described mainly in aneurisms in
and around the posterior cavernous sinus presenting acutelywith variable pain or anesthesia–hypoesthesia in the side of
the lesion.
We present five patients with VIth nerve palsy and ipsilat-
eral Horner’s Syndrome (HS), an association orienting diag-
nosis toward the cavernous sinus.Material and methods
Consecutive case series of five patients with horizontal
diplopia secondary to VIth nerve palsy and HS with ipsilateral
cavernous sinus lesion has been registered with the
institutional review board and followed the tenets of the
Declaration of Helsinki. After clinical diagnosis all patients
were asked for neuroimaging. The diagnosis of Hornere:
al.com
Figure 1. (a) RE VI nerve palsy and HS. (b) After Apraclonidine 0.5% midriasis
and lid retraction is observed. (c) Right CS tumor (squamous cell carcinoma).
Figure 2. (a and b) RE VI nerve palsy and HS. (c) Apraclonidine 0.5% response
after 40 min. (d) CT axial view shows a metallic foreign body at the right CS.
igure 3. (a and b) Left eye VI palsy and HS. (c) Apraclonidine 0.5%
sponse after 30 min. (d) Frozen image of carotid cine-Angiography, 1
teral and 2 frontal view, showing Intracavernous-carotid aneurysm.
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laSyndrome was performed by pharmacological test with
Apraclonidine 0.5% in order to confirm the sympathetic
denervation feature observed (Figs. 1–4).Results
Five patients are presented, with age range between 25
and 70 years, all patients had abducens palsy with horizontal
diplopia in primary position (3 patients) or evident in lateral
gaze only (2 patients) and ipsilateral Horner’s Syndrome
(Table 1). Apraclonidine 0.5% drops, evidenced sympathetic
denervation in all patients 40–60 min after instillation.
Patients had neuroimages (MRI in 3 cases, Computerized
Tomography – CT in one case and Magnetic Resonance
Angiography – MRA in one case) demonstrating cavernous
sinus lesions; 2 meningiomas, 1 carotid-cavernous aneurism,
1 foreign body (bullet) and 1 squamous cell carcinoma.Discussion
The cavernous sinus is a structure that contains, in its lat-
eral (meningeal) wall the oculomotor (IIIrd nerve), trochlear
(IVth nerve) and the first two divisions of the trigeminal nerve.
Inside the cavernous sinus, contains the abducens (VIth nerve)
Figure 4. (a) Ptosis and miosis on LE (HS). MRI; (b) axial and (c) coronal views showing images compatible with cavernous sinus meningioma.
Figure 5. (a) Carotid artery, (b) sympathetic plexus, (c) III nerve (superior
division), (d) IV nerve, (e) VI nerve, (f) III nerve (inferior division),
(g) Maxillary nerve.
Parkinson’s syndrome 65and the oculosympathetic nerve plexus around the internal
carotid artery.
These anatomical distributions are the cause of either
solitary or combined diverse impairments of cranial nerves
and eventual postganglionic Horner’s Syndrome.
Isolated VIth nerve palsy or Horner Syndrome alone, has
no localizing value per se, neuroimaging or pharmacological
tests are necessary to determine the injury site.
The association of VIth nerve palsy with ipsilateral HS,
described by Parkinson and named after him (PS),1,2 has a
great localizing value, being the cavernous sinus the site of
the lesion.
The sympathetic plexus and the VIth nerve attempt can be
explained by the close anatomical relationship between
these two elements inside the cavernous sinus (Fig. 5).
A single lesion may produce both deficits simultaneously.
The most frequent etiologies reported for PS are;
aneurism, invasive tumors, trauma, meningioma and giant
cell arteritis.3–7
In our small series of five cases we found two meningio-
mas, one carotid-cavernous aneurism, 1 foreign body (bullet)
and a squamous cell carcinoma as responsible for PS.
Neuroimaging (MRI, CT and Angiography) confirmed theTable 1. Clinical and ancillary findings in case series.
Patient Diplopia Apraclonidine 0
WC – 32 yrs (Fig. 3) Abd only +
CA – 27 yrs (Fig. 1) PPG +
JA – 67 yrs (Fig. 2) PPG +
MA – 58 yrs Abd only +
MC – 43 yrs PPG +
Abbreviations: PPG, primary position of gaze; abd, abduction; MR, Magnetic Resonance; CT
sinus; CC, carotid-cavernous.initial clinical diagnostic showing cavernous sinus lesions in
all our patients.
The use of Apraclonidine 0.5% has a great diagnostic
value for HS but does not provide information about the level
of the sympathetic pathway lesion. In our five cases helped to
confirm the presence of sympathetic denervation (ipsilateral
to the VI nerve deficit).8,9.5% CS imaging Findings
MR Squamous cell carcinoma
CT Metallic foreign body
MRA CC aneurysm
MR CC meningioma
MR CC meningioma
, Computerized Tomography; MRA, Magnetic Resonance Angiography; CS, cavernous
66 R.N. Ebner et al.In conclusion, neuroimaging of the cavernous sinus is rec-
ommended in the study of Parkinson’s Syndrome, choosing
images according to the nature of the suspected causing fac-
tor. Apraclonidine 0.5% is a helpful test for the detection of
sympathetic denervation.
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